Suppr超能文献

原发性可切除结直肠癌中免疫检查点蛋白与肿瘤微环境特征及预后的关系。

Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.

机构信息

Unit of Experimental Therapeutics, Institute of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, Glasgow, UK.

Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.

出版信息

J Pathol Clin Res. 2021 Mar;7(2):121-134. doi: 10.1002/cjp2.193. Epub 2020 Dec 18.

Abstract

The tumour microenvironment is an important factor for colorectal cancer prognosis, affecting the patient's immune response. Immune checkpoints, which regulate the immune functions of lymphocytes, may provide prognostic power. This study aimed to investigate the prognostic value of the immune checkpoints TIM-3, LAG-3 and PD-1 in patients with stage I-III colorectal cancer. Immunohistochemistry was employed to detect TIM-3, LAG-3, PD-1 and PD-L1 in 773 patients with stage I-III colorectal cancer. Immune checkpoint protein expression was assessed in tumour cells using the weighted histoscore, and in immune cells within the stroma using point counting. Scores were analysed for associations with survival and clinical factors. High tumoural LAG-3 (hazard ratio [HR] 1.45 95% confidence interval [CI] 1.00-2.09, p = 0.049) and PD-1 (HR 1.34 95% CI 1.00-1.78, p = 0.047) associated with poor survival, whereas high TIM-3 (HR 0.60 95% CI 0.42-0.84, p = 0.003), LAG-3 (HR 0.58 95% CI 0.40-0.87, p = 0.006) and PD-1 (HR 0.65 95% CI 0.49-0.86, p = 0.002) on immune cells within the stroma associated with improved survival, while PD-L1 in the tumour (p = 0.487) or the immune cells within the stroma (p = 0.298) was not associated with survival. Furthermore, immune cell LAG-3 was independently associated with survival (p = 0.017). Checkpoint expression scores on stromal immune cells were combined into a Combined Immune Checkpoint Stromal Score (CICSS), where CICSS 3 denoted all high, CICSS 2 denoted any two high, and CICSS 1 denoted other combinations. CICSS 3 was associated with improved patient survival (HR 0.57 95% CI 0.42-0.78, p = 0.001). The results suggest that individual and combined high expression of TIM-3, LAG-3, and PD-1 on stromal immune cells are associated with better colorectal cancer prognosis, suggesting there is added value to investigating multiple immune checkpoints simultaneously.

摘要

肿瘤微环境是结直肠癌预后的一个重要因素,影响患者的免疫反应。免疫检查点可调节淋巴细胞的免疫功能,可为预后提供依据。本研究旨在探讨免疫检查点 TIM-3、LAG-3 和 PD-1 在 I-III 期结直肠癌患者中的预后价值。采用免疫组化法检测 773 例 I-III 期结直肠癌患者的 TIM-3、LAG-3、PD-1 和 PD-L1。利用加权组织学评分评估肿瘤细胞中免疫检查点蛋白的表达,并用点计数法评估基质中免疫细胞的表达。分析评分与生存和临床因素的关系。肿瘤组织中高表达 LAG-3(危险比 [HR] 1.45,95%置信区间 [CI] 1.00-2.09,p = 0.049)和 PD-1(HR 1.34,95%CI 1.00-1.78,p = 0.047)与生存不良相关,而肿瘤组织中高表达 TIM-3(HR 0.60,95%CI 0.42-0.84,p = 0.003)、LAG-3(HR 0.58,95%CI 0.40-0.87,p = 0.006)和 PD-1(HR 0.65,95%CI 0.49-0.86,p = 0.002)与基质中免疫细胞的表达与生存改善相关,而肿瘤组织中的 PD-L1(p = 0.487)或基质中的免疫细胞(p = 0.298)与生存无关。此外,免疫细胞 LAG-3 与生存独立相关(p = 0.017)。将基质免疫细胞的免疫检查点表达评分组合成联合免疫检查点基质评分(CICSS),其中 CICSS 3 表示所有高,CICSS 2 表示任意两个高,CICSS 1 表示其他组合。CICSS 3 与患者生存改善相关(HR 0.57,95%CI 0.42-0.78,p = 0.001)。结果表明,TIM-3、LAG-3 和 PD-1 在基质免疫细胞上的单独和联合高表达与结直肠癌预后较好相关,这表明同时研究多个免疫检查点具有附加价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f49d/7869939/fe0c2457b293/CJP2-7-121-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验